Society Pass Incorporated (Nasdaq: SOPA) and Thoughtful Media Group Incorporated 
USAS Building System Advances Toward Hong Kong Listing: A Top-Three Industrial Prefabricated Steel Structure Solution Provider, with an Emerging Overseas Growth Curve 
PerfectlyHost Announces New Comprehensive Digital Services Platform to Simplify Online Operations for Small Businesses Relay Therapeutics Announces Pricing of Public Offering of Common Stock
CAMBRIDGE, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage…
Fireside Chat with Enochian BioSciences’ CEO, Dr. Mark Dybul at H.C. Wainwright 2nd Annual Hepatitis B Virus (HBV) Conference
LOS ANGELES, Oct. 12, 2021 (GLOBE NEWSWIRE) — (NASDAQ: ENOB) − Enochian BioSciences, a company…
Travere Therapeutics Announces Transition of Chief Medical Officer
SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
Cellectis to Present Preclinical Data on UCARTMESO Supporting Anti-Tumor Activity at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
NEW YORK, Oct. 12, 2021 (GLOBE NEWSWIRE) — Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH:…
Resverlogix Receives Ethics Approval for Canadian Sites in Apabetalone COVID-19 Clinical Trial
Study Approval Paves the Way for Trial Participants to Begin Taking Apabetalone CALGARY, Alberta, Oct….
Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2021
Monthly information regarding the total number of voting rights and total number of shares of…
Neuronetics Announces Preliminary Revenue for Third Quarter 2021
MALVERN, Pa., Oct. 12, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical…
Satsuma Pharmaceuticals Announces the Appointment of Mutya Harsch to its Board of Directors
SOUTH SAN FRANCISCO, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA),…
Adicet Announces Promotion of Blake Aftab, Ph.D. to Chief Scientific Officer
MENLO PARK, Calif. and BOSTON, Oct. 12, 2021 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (Nasdaq:…
Evaxion Biotech to Present Work on AI-Immunology Core Technology at Immuno UK 2021
COPENHAGEN, Denmark, Oct. 12, 2021 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or…
Morphic to Participate in Jefferies IBD Therapeutics Summit
WALTHAM, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biotechnology company…
Homology Medicines Announces World’s First Gene Editing Clinical Trial for PKU
– IND Clearance of pheEDIT Study to Evaluate a One-Time Dose of Investigational HMI-103 Incorporating…
Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants, and a Concurrent Registered Direct Offering
REDWOOD CITY, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or…
Seer to Report Third Quarter Financial Results on November 9, 2021
REDWOOD CITY, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life…
CRISPR Therapeutics Reports Positive Results from its Phase 1 CARBON Trial of CTX110™ in Relapsed or Refractory CD19+ B-cell malignancies
-58% overall response rate (ORR) and 38% complete response (CR) rate in large B-cell lymphoma…
Prometheus Biosciences to Present at Jefferies Virtual Next Generation IBD Therapeutics Summit
SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) — Prometheus Biosciences, Inc. (Nasdaq: RXDX), today announced…
EyePoint Pharmaceuticals Presents Preliminary Safety Data from Phase 1 DAVIO Trial and YUTIQ® CALM Registry Study at American Society of Retina Specialists (ASRS) 39th Annual Meeting
– 3-month safety data from DAVIO trial continues to demonstrate EYP-1901 is well-tolerated in eyes…
About the received documents
Joint Stock Company “Olainfarm”, hereinafter – the Company, has received from Black Duck Invest a.s….
Skye Bioscience Establishes New Cannabinoid Pharmaceutical Innovation Program
Exclusive sponsored research agreement with endocannabinoid research pioneers SAN DIEGO, CA, Oct. 12, 2021 (GLOBE…
Ultimovacs ASA: Share capital increase related to exercise of options
Oslo, 12 October 2021, the Board of Directors of Ultimovacs ASA (the “Company”) has resolved…